Načítá se...

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

PURPOSE: To compare health-related quality of life (HRQOL) of high-dose-rate brachytherapy (HDRB) versus low dose-rate brachytherapy (LDRB) for localized prostate cancer in a multi-institutional phase 2 randomized trial. METHODS AND MATERIALS: Men with favorable-risk prostate cancer were randomized...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Adv Radiat Oncol
Hlavní autoři: Hathout, Lara, Mahmoud, Omar, Wang, Yaqun, Vergalasova, Irina, Barkati, Maroie, Després, Philippe, Martin, André-Guy, Foster, William, Lacroix, Frédéric, Delouya, Guila, Taussky, Daniel, Morton, Gerard, Vigneault, Eric
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6817536/
https://ncbi.nlm.nih.gov/pubmed/31673656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.adro.2019.04.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!